MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
Over the last decade, adherent MDCK (Madin Darby canine kidney) and Vero cells have attracted considerable attention for production of cell culture-derived influenza vaccines. While numerous publications deal with the design and the optimization of corresponding upstream processes, one-to-one compar...
Gespeichert in:
Veröffentlicht in: | Applied microbiology and biotechnology 2010-09, Vol.88 (2), p.461-475 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 475 |
---|---|
container_issue | 2 |
container_start_page | 461 |
container_title | Applied microbiology and biotechnology |
container_volume | 88 |
creator | Genzel, Yvonne Dietzsch, Christian Rapp, Erdmann Schwarzer, Jana Reichl, Udo |
description | Over the last decade, adherent MDCK (Madin Darby canine kidney) and Vero cells have attracted considerable attention for production of cell culture-derived influenza vaccines. While numerous publications deal with the design and the optimization of corresponding upstream processes, one-to-one comparisons of these cell lines under comparable cultivation conditions have largely been neglected. Therefore, a direct comparison of influenza virus production with adherent MDCK and Vero cells in T-flasks, roller bottles, and lab-scale bioreactors was performed in this study. First, virus seeds had to be adapted to Vero cells by multiple passages. Glycan analysis of the hemagglutinin (HA) protein showed that for influenza A/PR/8/34 H1N1, three passages were sufficient to achieve a stable new N-glycan fingerprint, higher yields, and a faster increase to maximum HA titers. Compared to MDCK cells, virus production in serum-free medium with Vero cells was highly sensitive to trypsin concentration. Virus stability at 37 °C for different virus strains showed differences depending on medium, virus strain, and cell line. After careful adjustment of corresponding parameters, comparable productivity was obtained with both host cell lines in small-scale cultivation systems. However, using these cultivation conditions in lab-scale bioreactors (stirred tank, wave bioreactor) resulted in lower productivities for Vero cells. |
doi_str_mv | 10.1007/s00253-010-2742-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7080112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2190592841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-88807e85b6bac695938da7221639fd81fef1f08298820e72f83d5abdce5e1e723</originalsourceid><addsrcrecordid>eNqFkk2PFCEQhjtG486u_gAvSkw2ntACpht6DyZm_IxrPOh6JdU0jGx6YITuSdxfL-2Mu-pBL1SAp16qireqHjB4ygDkswzAa0GBAeVyyWl7q1qwpeAUGra8XS2AyZrKulVH1XHOlwCMq6a5Wx3xAkjB2KK6-vBy9Z5g6MkXmyIxdhgycTERH9ww2XCFZOfTlMkOjfHBkm2K_WRGH8MZQRKDpWOkJRATN1tMPsdApi0ZIxmwo9ngYEnnY7JoxiJrpmH0O5zz71V3HA7Z3j_Ek-ri9avPq7f0_OObd6sX59TU9XKkSimQVtVd06Fp2roVqkfJOWtE63rFnHXMgeKtUhys5E6JvsauN7a2rOzFSfV8r7uduo0t52FMOOht8htM33VEr_-8Cf6rXsedlqCAsVngyUEgxW-TzaPe-DxPCoONU9ZlwoKDrNX_yaVqZVGEQj7-i7yMUwplDlq2XDaq_QmxPWRSzDlZd100Az07QO8doIsD9OwA3Zach793e53x68sLcHoAcP4dlzAYn284wZkEmHvhey6Xq7C26abCf73-aJ_kMGpcFzvoi08cmACmlCir-AEqnNK_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>792768930</pqid></control><display><type>article</type><title>MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Genzel, Yvonne ; Dietzsch, Christian ; Rapp, Erdmann ; Schwarzer, Jana ; Reichl, Udo</creator><creatorcontrib>Genzel, Yvonne ; Dietzsch, Christian ; Rapp, Erdmann ; Schwarzer, Jana ; Reichl, Udo</creatorcontrib><description>Over the last decade, adherent MDCK (Madin Darby canine kidney) and Vero cells have attracted considerable attention for production of cell culture-derived influenza vaccines. While numerous publications deal with the design and the optimization of corresponding upstream processes, one-to-one comparisons of these cell lines under comparable cultivation conditions have largely been neglected. Therefore, a direct comparison of influenza virus production with adherent MDCK and Vero cells in T-flasks, roller bottles, and lab-scale bioreactors was performed in this study. First, virus seeds had to be adapted to Vero cells by multiple passages. Glycan analysis of the hemagglutinin (HA) protein showed that for influenza A/PR/8/34 H1N1, three passages were sufficient to achieve a stable new N-glycan fingerprint, higher yields, and a faster increase to maximum HA titers. Compared to MDCK cells, virus production in serum-free medium with Vero cells was highly sensitive to trypsin concentration. Virus stability at 37 °C for different virus strains showed differences depending on medium, virus strain, and cell line. After careful adjustment of corresponding parameters, comparable productivity was obtained with both host cell lines in small-scale cultivation systems. However, using these cultivation conditions in lab-scale bioreactors (stirred tank, wave bioreactor) resulted in lower productivities for Vero cells.</description><identifier>ISSN: 0175-7598</identifier><identifier>EISSN: 1432-0614</identifier><identifier>DOI: 10.1007/s00253-010-2742-9</identifier><identifier>PMID: 20617311</identifier><identifier>CODEN: AMBIDG</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Adaptation ; Analysis ; Animals ; Biological and medical sciences ; Biomedical and Life Sciences ; Bioreactor ; Bioreactors ; Biotechnological Products and Process Engineering ; Biotechnology ; Cell culture ; Cell Culture Techniques ; Chlorocebus aethiops ; Cultivation ; Dogs ; Eggs ; Fundamental and applied biological sciences. Psychology ; glycosylation ; Infections ; Influenza ; Influenza A Virus, H1N1 Subtype - growth & development ; Influenza Vaccines - biosynthesis ; Influenza virus ; Life Sciences ; Membrane reactors ; Methods. Procedures. Technologies ; Microbial Genetics and Genomics ; Microbiology ; Productivity ; Studies ; TCID₅₀ stability ; trypsin ; Vaccine production ; Vaccines ; Various methods and equipments ; Vero Cells ; Virus Cultivation - methods ; Viruses</subject><ispartof>Applied microbiology and biotechnology, 2010-09, Vol.88 (2), p.461-475</ispartof><rights>Springer-Verlag 2010</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-88807e85b6bac695938da7221639fd81fef1f08298820e72f83d5abdce5e1e723</citedby><cites>FETCH-LOGICAL-c554t-88807e85b6bac695938da7221639fd81fef1f08298820e72f83d5abdce5e1e723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00253-010-2742-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00253-010-2742-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23217008$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20617311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Genzel, Yvonne</creatorcontrib><creatorcontrib>Dietzsch, Christian</creatorcontrib><creatorcontrib>Rapp, Erdmann</creatorcontrib><creatorcontrib>Schwarzer, Jana</creatorcontrib><creatorcontrib>Reichl, Udo</creatorcontrib><title>MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation</title><title>Applied microbiology and biotechnology</title><addtitle>Appl Microbiol Biotechnol</addtitle><addtitle>Appl Microbiol Biotechnol</addtitle><description>Over the last decade, adherent MDCK (Madin Darby canine kidney) and Vero cells have attracted considerable attention for production of cell culture-derived influenza vaccines. While numerous publications deal with the design and the optimization of corresponding upstream processes, one-to-one comparisons of these cell lines under comparable cultivation conditions have largely been neglected. Therefore, a direct comparison of influenza virus production with adherent MDCK and Vero cells in T-flasks, roller bottles, and lab-scale bioreactors was performed in this study. First, virus seeds had to be adapted to Vero cells by multiple passages. Glycan analysis of the hemagglutinin (HA) protein showed that for influenza A/PR/8/34 H1N1, three passages were sufficient to achieve a stable new N-glycan fingerprint, higher yields, and a faster increase to maximum HA titers. Compared to MDCK cells, virus production in serum-free medium with Vero cells was highly sensitive to trypsin concentration. Virus stability at 37 °C for different virus strains showed differences depending on medium, virus strain, and cell line. After careful adjustment of corresponding parameters, comparable productivity was obtained with both host cell lines in small-scale cultivation systems. However, using these cultivation conditions in lab-scale bioreactors (stirred tank, wave bioreactor) resulted in lower productivities for Vero cells.</description><subject>Adaptation</subject><subject>Analysis</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Bioreactor</subject><subject>Bioreactors</subject><subject>Biotechnological Products and Process Engineering</subject><subject>Biotechnology</subject><subject>Cell culture</subject><subject>Cell Culture Techniques</subject><subject>Chlorocebus aethiops</subject><subject>Cultivation</subject><subject>Dogs</subject><subject>Eggs</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>glycosylation</subject><subject>Infections</subject><subject>Influenza</subject><subject>Influenza A Virus, H1N1 Subtype - growth & development</subject><subject>Influenza Vaccines - biosynthesis</subject><subject>Influenza virus</subject><subject>Life Sciences</subject><subject>Membrane reactors</subject><subject>Methods. Procedures. Technologies</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Productivity</subject><subject>Studies</subject><subject>TCID₅₀ stability</subject><subject>trypsin</subject><subject>Vaccine production</subject><subject>Vaccines</subject><subject>Various methods and equipments</subject><subject>Vero Cells</subject><subject>Virus Cultivation - methods</subject><subject>Viruses</subject><issn>0175-7598</issn><issn>1432-0614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkk2PFCEQhjtG486u_gAvSkw2ntACpht6DyZm_IxrPOh6JdU0jGx6YITuSdxfL-2Mu-pBL1SAp16qireqHjB4ygDkswzAa0GBAeVyyWl7q1qwpeAUGra8XS2AyZrKulVH1XHOlwCMq6a5Wx3xAkjB2KK6-vBy9Z5g6MkXmyIxdhgycTERH9ww2XCFZOfTlMkOjfHBkm2K_WRGH8MZQRKDpWOkJRATN1tMPsdApi0ZIxmwo9ngYEnnY7JoxiJrpmH0O5zz71V3HA7Z3j_Ek-ri9avPq7f0_OObd6sX59TU9XKkSimQVtVd06Fp2roVqkfJOWtE63rFnHXMgeKtUhys5E6JvsauN7a2rOzFSfV8r7uduo0t52FMOOht8htM33VEr_-8Cf6rXsedlqCAsVngyUEgxW-TzaPe-DxPCoONU9ZlwoKDrNX_yaVqZVGEQj7-i7yMUwplDlq2XDaq_QmxPWRSzDlZd100Az07QO8doIsD9OwA3Zach793e53x68sLcHoAcP4dlzAYn284wZkEmHvhey6Xq7C26abCf73-aJ_kMGpcFzvoi08cmACmlCir-AEqnNK_</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Genzel, Yvonne</creator><creator>Dietzsch, Christian</creator><creator>Rapp, Erdmann</creator><creator>Schwarzer, Jana</creator><creator>Reichl, Udo</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QH</scope><scope>7QO</scope><scope>7U9</scope><scope>7UA</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20100901</creationdate><title>MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation</title><author>Genzel, Yvonne ; Dietzsch, Christian ; Rapp, Erdmann ; Schwarzer, Jana ; Reichl, Udo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-88807e85b6bac695938da7221639fd81fef1f08298820e72f83d5abdce5e1e723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adaptation</topic><topic>Analysis</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Bioreactor</topic><topic>Bioreactors</topic><topic>Biotechnological Products and Process Engineering</topic><topic>Biotechnology</topic><topic>Cell culture</topic><topic>Cell Culture Techniques</topic><topic>Chlorocebus aethiops</topic><topic>Cultivation</topic><topic>Dogs</topic><topic>Eggs</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>glycosylation</topic><topic>Infections</topic><topic>Influenza</topic><topic>Influenza A Virus, H1N1 Subtype - growth & development</topic><topic>Influenza Vaccines - biosynthesis</topic><topic>Influenza virus</topic><topic>Life Sciences</topic><topic>Membrane reactors</topic><topic>Methods. Procedures. Technologies</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Productivity</topic><topic>Studies</topic><topic>TCID₅₀ stability</topic><topic>trypsin</topic><topic>Vaccine production</topic><topic>Vaccines</topic><topic>Various methods and equipments</topic><topic>Vero Cells</topic><topic>Virus Cultivation - methods</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Genzel, Yvonne</creatorcontrib><creatorcontrib>Dietzsch, Christian</creatorcontrib><creatorcontrib>Rapp, Erdmann</creatorcontrib><creatorcontrib>Schwarzer, Jana</creatorcontrib><creatorcontrib>Reichl, Udo</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Aqualine</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Water Resources Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Applied microbiology and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Genzel, Yvonne</au><au>Dietzsch, Christian</au><au>Rapp, Erdmann</au><au>Schwarzer, Jana</au><au>Reichl, Udo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation</atitle><jtitle>Applied microbiology and biotechnology</jtitle><stitle>Appl Microbiol Biotechnol</stitle><addtitle>Appl Microbiol Biotechnol</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>88</volume><issue>2</issue><spage>461</spage><epage>475</epage><pages>461-475</pages><issn>0175-7598</issn><eissn>1432-0614</eissn><coden>AMBIDG</coden><abstract>Over the last decade, adherent MDCK (Madin Darby canine kidney) and Vero cells have attracted considerable attention for production of cell culture-derived influenza vaccines. While numerous publications deal with the design and the optimization of corresponding upstream processes, one-to-one comparisons of these cell lines under comparable cultivation conditions have largely been neglected. Therefore, a direct comparison of influenza virus production with adherent MDCK and Vero cells in T-flasks, roller bottles, and lab-scale bioreactors was performed in this study. First, virus seeds had to be adapted to Vero cells by multiple passages. Glycan analysis of the hemagglutinin (HA) protein showed that for influenza A/PR/8/34 H1N1, three passages were sufficient to achieve a stable new N-glycan fingerprint, higher yields, and a faster increase to maximum HA titers. Compared to MDCK cells, virus production in serum-free medium with Vero cells was highly sensitive to trypsin concentration. Virus stability at 37 °C for different virus strains showed differences depending on medium, virus strain, and cell line. After careful adjustment of corresponding parameters, comparable productivity was obtained with both host cell lines in small-scale cultivation systems. However, using these cultivation conditions in lab-scale bioreactors (stirred tank, wave bioreactor) resulted in lower productivities for Vero cells.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>20617311</pmid><doi>10.1007/s00253-010-2742-9</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0175-7598 |
ispartof | Applied microbiology and biotechnology, 2010-09, Vol.88 (2), p.461-475 |
issn | 0175-7598 1432-0614 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7080112 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adaptation Analysis Animals Biological and medical sciences Biomedical and Life Sciences Bioreactor Bioreactors Biotechnological Products and Process Engineering Biotechnology Cell culture Cell Culture Techniques Chlorocebus aethiops Cultivation Dogs Eggs Fundamental and applied biological sciences. Psychology glycosylation Infections Influenza Influenza A Virus, H1N1 Subtype - growth & development Influenza Vaccines - biosynthesis Influenza virus Life Sciences Membrane reactors Methods. Procedures. Technologies Microbial Genetics and Genomics Microbiology Productivity Studies TCID₅₀ stability trypsin Vaccine production Vaccines Various methods and equipments Vero Cells Virus Cultivation - methods Viruses |
title | MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MDCK%20and%20Vero%20cells%20for%20influenza%20virus%20vaccine%20production:%20a%20one-to-one%20comparison%20up%20to%20lab-scale%20bioreactor%20cultivation&rft.jtitle=Applied%20microbiology%20and%20biotechnology&rft.au=Genzel,%20Yvonne&rft.date=2010-09-01&rft.volume=88&rft.issue=2&rft.spage=461&rft.epage=475&rft.pages=461-475&rft.issn=0175-7598&rft.eissn=1432-0614&rft.coden=AMBIDG&rft_id=info:doi/10.1007/s00253-010-2742-9&rft_dat=%3Cproquest_pubme%3E2190592841%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=792768930&rft_id=info:pmid/20617311&rfr_iscdi=true |